Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Search content at University of Luebeck
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Media
Activities
Datasets
Inhibition of GSK3α/β impairs the progression of HNSCC
Lisa Schulz,
Ralph Pries
, Aruna Sree Lanka, Maren Drenckhan,
Dirk Rades
, Barbara Wollenberg
*
*
Corresponding author for this work
Department of Otorhinolaryngology, Phoniatrics and Pediatric Audiology
Department of Radiotherapy
6
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of GSK3α/β impairs the progression of HNSCC'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Cell
100%
Neck
100%
Glycogen Synthase Kinase 3
100%
Squamous Cell
100%
Mesenchymal-Epithelial Transition
44%
Cancer Cell Line
33%
Neoplasm
22%
Cancer Growth
22%
Inflammatory Cytokine
22%
Glycogen Synthase Kinase 3 Inhibitor
22%
Immunohistochemistry
11%
Toll Like Receptor 3
11%
Experimental Therapy
11%
Tumor Necrosis Factor
11%
Base
11%
Western Blot
11%
Cytokine
11%
Cell Migration
11%
Toll Like Receptor 4
11%
Tumor Suppressor Protein
11%
Immunology and Microbiology
Squamous Cell
100%
Neck
100%
Epithelial Mesenchymal Transition
50%
Inflammatory Cytokine
25%
Cancer Cell Line
25%
TLR3
12%
Western Blot
12%
Tumor Necrosis Factor
12%
Growth Inhibition
12%
TLR4
12%
Promoter Region
12%
Cell Migration
12%
Cytokine
12%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Glycogen Synthase Kinase 3
100%
Cytokine
33%
Neoplasm
22%
Cancer Growth
22%
Cell Viability
11%
Tumor Suppressor Protein
11%
Toll Like Receptor 4
11%
Tumor Promoter
11%
Western Blot
11%
Tumor Necrosis Factor
11%
Base
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Mesenchymal-Epithelial Transition
36%
Inflammatory Cytokine
18%
Wound Healing Assay
9%
Cell Migration
9%
Cytokine
9%
Tumor Suppressor Protein
9%
Western Blot
9%
TLR4
9%
Regulatory Network
9%
Promoter Region
9%